Back

Prognostic value of NYHA functional class in heart failure patients undergoing primary prevention implantable cardioverter defibrillator therapy.

3 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 6 - Arrhythmias and devices in heart failure Implantable Cardioverter-Defibrillator (ICD) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Sem Briongos Figuero

Public Company Hospital de Vallecas - Hospital Infanta Leonor, Madrid (Spain)

9 More presentations in this session

Presentation thumbnail
Professor V. Kuznetsov (Tyumen, RU)
Abstract Slides
Presentation thumbnail
Doctor A. Ciesielski (Nowa Sol, PL)
Abstract Slides
Presentation thumbnail
Doctor O. Itzhaki Ben Zadok (Petah Tikva, IL)
Abstract
Presentation thumbnail
Doctor E. Hameli (Rotterdam, NL)
Abstract
Presentation thumbnail
Assistant Professor J. Duchenne (Hasselt, BE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Arrhythmias and devices in heart failure

The Event

Event poster

ESC Congress 2019

3 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Session
Debate on primary prevention in ICD therapy
thumbnail
Congress Session
Arrhythmias and devices
thumbnail
Congress Session
When to consider device therapy in HFrEF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources